Author:
Popović Dušanka,Malešević Anastasija,Tucović Dina,Kulaš Jelena,Popov-Aleksandrov Aleksandra,Mirkov Ivana
Abstract
Bacterial microbiota of the gastrointestinal tract is known to prevent the invasion of pathogenic microorganisms and regulate intestinal permeability, digestion, metabolism, and immune response. It affects function, homeostasis, and disease outcomes in the gastrointestinal tract and extra-intestinal sites such as the lungs. This review summarizes the currently available knowledge regarding the gut-lung axis. The association of bacterial composition and/or dysbiosis in the gut with asthma, chronic obstructive lung disease, cystic fibrosis, recurrent respiratory tract infections, and lung cancer in humans is highlighted, as well as data obtained from animal models of pulmonary inflammation, which indicated that modulation of immune system activity lies at the base of this interaction. Additionally, the potential use of prebiotics, probiotics, and postbiotics in the treatment of lung inflammation is presented.
Funder
Ministry of Education, Science and Technological Development of the Republic of Serbia
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Subject
Pharmaceutical Science,Pharmacology
Reference95 articles.
1. Sommer F, Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227-38;
2. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous system. Ann Gastroenterol. 2015;28(2):203-9;
3. De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms. 2021;9(2):353;
4. Ma PJ, Wang MM, Wnag Y. Gut microbiota: A new insight into lung diseases. Biomed Pharmacother. 2022;155:113810;
5. Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(6):1469-85;